AI in Diabetes Management: Global Market Outlook

Apr 2023| IFT273A| BCC Publishing
Sample Report

Report Highlights

This report presents an in-depth assessment of the global market outlook for artificial intelligence (AI) in diabetes management. The study includes AI in diabetes management care platforms and associated services. It covers the impact of macroeconomic factors affecting the global market for AI in diabetes management. The report examines emerging market trends, and underlying future opportunities in the market. The report concludes with the company profiles of leading market participants and their offerings in AI in diabetes management products, solutions and services.

Report Includes

  • A brief general outlook of the global market for artificial intelligence (AI) in diabetic management
  • Analyses of the global market trends, with historic market revenue for 2021, estimates for 2022, forecasts for 2023 and 2025, and projections of compound annual growth rates (CAGRs) through 2027
  • Understanding of the upcoming market potential for AI in diabetic mellitus management with an emphasis on new products and solutions/platform technologies, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and revenue forecast for the AI in diabetic management market, and corresponding market share analysis product type, technique, and region
  • In-depth information (facts and figures) on the major market dynamics, opportunities and gaps estimating the demand, technology adaptations in diabetes care, industry developments, regulatory dynamics, and Covid-19 impact on the progress of this market
  • Identification of the companies best positioned to meet this demand owing to or in conjunction with their proprietary technologies, product launches, and other strategic advantages
  • Company profiles of the major global players

Report Scope

In this report, the market has been segmented based on product type, technique and geographic region. The report provides an overview of the global market for AI in diabetes management and analyzes market trends. Using 2021 as the base year, the report provides estimated market data and revenue projections for the forecast period of 2022-2027. Market values have been estimated based on the total revenue of providers of AI in diabetes management products.

The scope of the study includes AI in diabetes management care platforms and associated services.

Frequently Asked Questions (FAQs)

The AI in diabetes management market is projected to grow from $457.4 million in 2021 to $2.1 billion by 2027, at a compound annual growth rate (CAGR) of 30.2% during the forecast period.
The key factors driving the growth of AI in diabetes management market includes:
  • Technological Advances in Diabetes Preventive Care
  • Growing Elderly Population
  • Growing Demand for Real-time Monitoring and Improved Patient Engagement
The AI in diabetes management market is segmented based on product type, technique and region.
Glucose monitoring device segment will dominate the market by the end of 2027.
North America holds the highest market share in the market in terms of region.
Key companies in the market includes Apple Inc., Abbott, and Medtronic.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $457.4 million
Market size forecast $2.1 billion
Growth rate CAGR of 30.2% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered By Product Type, Technique, and Region
Regions covered North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA)
Key Market Drivers
  • Growing Elderly Population
  • Technological Advances in Diabetes Preventive Care
  • Growing Demand for Real-time Monitoring and Improved Patient Engagement
Companies studied
  • ABBOTT
  • BIGFOOT BIOMEDICAL INC.
  • CARDINAL HEALTH INC.
  • DREAMED DIABETES LTD.
  • EYENUK INC.
  • GLOOKO INC.
  • GOOGLE INC.
  • HEALTH ARX TECHNOLOGIES PRIVATE LTD.
  • MEDTRONIC
  • VIRTA HEALTH CORP.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
. Title/Chapter NamePagesPrice Member Price
Full Report: AI in Diabetes Management: Global Market Outlook49 $3,500 Free
AI in Diabetes Management: Global Market Outlook

Single User License: $3500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS